KR20220087499A - 연골 보호용의 의약 조성물 - Google Patents

연골 보호용의 의약 조성물 Download PDF

Info

Publication number
KR20220087499A
KR20220087499A KR1020227016836A KR20227016836A KR20220087499A KR 20220087499 A KR20220087499 A KR 20220087499A KR 1020227016836 A KR1020227016836 A KR 1020227016836A KR 20227016836 A KR20227016836 A KR 20227016836A KR 20220087499 A KR20220087499 A KR 20220087499A
Authority
KR
South Korea
Prior art keywords
ylazo
amino
naphthalene
pyridin
sulfonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020227016836A
Other languages
English (en)
Korean (ko)
Inventor
고헤이 니시타니
아키라 가키즈카
하나코 이케다
슈이치 마츠다
사치코 이와이
모토오 사이토
구니히로 무사시
Original Assignee
고쿠리츠 다이가쿠 호진 교토 다이가쿠
가부시키가이샤 교토 소야쿠 겐큐쇼
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고쿠리츠 다이가쿠 호진 교토 다이가쿠, 가부시키가이샤 교토 소야쿠 겐큐쇼 filed Critical 고쿠리츠 다이가쿠 호진 교토 다이가쿠
Publication of KR20220087499A publication Critical patent/KR20220087499A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020227016836A 2019-10-24 2020-10-23 연골 보호용의 의약 조성물 Withdrawn KR20220087499A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019193329 2019-10-24
JPJP-P-2019-193329 2019-10-24
PCT/JP2020/039896 WO2021079983A1 (ja) 2019-10-24 2020-10-23 軟骨保護用の医薬組成物

Publications (1)

Publication Number Publication Date
KR20220087499A true KR20220087499A (ko) 2022-06-24

Family

ID=75619826

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227016836A Withdrawn KR20220087499A (ko) 2019-10-24 2020-10-23 연골 보호용의 의약 조성물

Country Status (6)

Country Link
US (1) US20220401461A1 (https=)
EP (1) EP4049724A4 (https=)
JP (1) JPWO2021079983A1 (https=)
KR (1) KR20220087499A (https=)
CN (1) CN114599370A (https=)
WO (1) WO2021079983A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023120704A1 (ja) 2021-12-24 2023-06-29 国立大学法人京都大学 心機能を改善するための組成物
EP4628084A1 (en) * 2022-11-28 2025-10-08 Kyoto University Naphthalene-derivative-based therapeutic drug for ophthalmological disease

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012014994A1 (ja) 2010-07-30 2012-02-02 ダイトーケミックス株式会社 ナフタレン誘導体
WO2012043891A1 (ja) 2010-09-30 2012-04-05 ダイトーケミックス株式会社 眼疾患処置薬
WO2014129495A1 (ja) 2013-02-20 2014-08-28 国立大学法人京都大学 眼疾患処置薬
WO2015033981A1 (ja) 2013-09-04 2015-03-12 国立大学法人京都大学 レプチン抵抗性を改善する医薬組成物
WO2015129809A1 (ja) 2014-02-28 2015-09-03 国立大学法人京都大学 虚血性眼疾患の処置用の医薬組成物
WO2019131720A1 (ja) 2017-12-27 2019-07-04 国立大学法人京都大学 角膜保護用の組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008254425A1 (en) * 2007-05-21 2008-11-27 Novartis Ag CSF-1R inhibitors, compositions, and methods of use
US9056105B2 (en) * 2008-07-25 2015-06-16 Indiana University Research And Technology Corporation Method for treatment of bone diseases and fractures
WO2010038153A1 (en) * 2008-10-01 2010-04-08 The University Of British Columbia Use of sox transcription factor acti\ators for stimulating chondrogenesis
WO2014207241A1 (en) * 2013-06-28 2014-12-31 Alzprotect NEW Na-SUBSTITUTED CARBOLINE COMPOUNDS USABLE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
CN105586389A (zh) * 2014-10-21 2016-05-18 天津华大基因科技有限公司 试剂盒及其在检测遗传性骨病基因中的用途
JP2019193329A (ja) 2018-04-18 2019-10-31 パナソニックＩｐマネジメント株式会社 平面モータシステム

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012014994A1 (ja) 2010-07-30 2012-02-02 ダイトーケミックス株式会社 ナフタレン誘導体
WO2012043891A1 (ja) 2010-09-30 2012-04-05 ダイトーケミックス株式会社 眼疾患処置薬
WO2014129495A1 (ja) 2013-02-20 2014-08-28 国立大学法人京都大学 眼疾患処置薬
WO2015033981A1 (ja) 2013-09-04 2015-03-12 国立大学法人京都大学 レプチン抵抗性を改善する医薬組成物
WO2015129809A1 (ja) 2014-02-28 2015-09-03 国立大学法人京都大学 虚血性眼疾患の処置用の医薬組成物
WO2019131720A1 (ja) 2017-12-27 2019-07-04 国立大学法人京都大学 角膜保護用の組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Sakata S, et al., J Orthop Res. 2015 Mar; 33(3): 359-65.
Yazici Y, et al., Osteoarthritis Cartilage. 2017 Oct; 25(10): 1598-1606.

Also Published As

Publication number Publication date
JPWO2021079983A1 (https=) 2021-04-29
US20220401461A1 (en) 2022-12-22
WO2021079983A1 (ja) 2021-04-29
EP4049724A4 (en) 2023-05-03
EP4049724A1 (en) 2022-08-31
CN114599370A (zh) 2022-06-07

Similar Documents

Publication Publication Date Title
KR102926644B1 (ko) 골관절염의 치료
RU2700582C2 (ru) Схема применения соединения fgf-18
KR101519028B1 (ko) 항혈관형성제 및 사용방법
JP2013513657A (ja) 新規ペプチドおよびその用途
KR20220087499A (ko) 연골 보호용의 의약 조성물
Yang et al. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis
JP6243996B2 (ja) Ｂｃａｔ１阻害剤を使用する治療方法
US20120295935A1 (en) Mixed aminal pharmaceutical compositions and uses thereof
CN114404434B (zh) 一种治疗骨关节炎的化合物及其用途
US9056105B2 (en) Method for treatment of bone diseases and fractures
JP2020517706A (ja) ヒトｂｍｐ７タンパク質のバリアント
KR102285724B1 (ko) Dna 단편 혼합물 및 히알루론산을 포함하는 연골 재생용 조성물
CN116270564A (zh) 4,3&#39;,5&#39;-三羟基白藜芦醇类化合物在制备冠状病毒3cl蛋白酶抑制剂中的应用
KR20240038995A (ko) 골관절염의 치료에서의 nlrp3 저해제를 위한 투여 계획
WO2020119614A1 (en) A compound for treating osteoarthritis
CN116490173B (zh) 包括苯溴马隆的用于预防或治疗伤口或疤痕的药物组合物
WO2000078305A1 (fr) Remedes contre la polyarthrite rhumatoide
JP6429401B2 (ja) 変異を有するｉ型コラーゲンの小胞体内過剰蓄積正常化剤
KR100909867B1 (ko) 골대사성 질환의 예방 및 치료를 위한 조성물
JPH08508013A (ja) 平滑筋細胞増殖の阻害についてのカルバゾリル−▲（４）▼−オキシプロパノールアミン化合物の使用および該化合物を用いる治療法
TW202333660A (zh) 軟骨再生促進劑
CA3004506C (en) Use of n-(5-(3-(7-(3- fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide in the treatment of osteoarthritis
RU2191006C2 (ru) Способ лечения диссеминированной формы остеогенной саркомы
JP2005089457A (ja) 骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
WO2020262527A1 (ja) 筋再生促進剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203